Inventor · disambiguated record
Saurabh Saha
Also filed as: SAHA SAURABH
37 granted patents·13 pending applications·121 citations·filing 2004–2025
96Inventor score
Files withBIOMED VALLEY DISCOVERIES INC33SYNLOGIC OPERATING CO INC4UNIV JOHNS HOPKINS3US HEALTH3THE UNITED STATES OF AMERICA AS PRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES2
Top patents by PatentIndex Score
50 records- 0196US9790282B2Anti-CD276 polypeptides, proteins, and chimeric antigen receptorsUS HEALTH·Filed 2014·Granted Oct 17, 2017·28 cites·29 claims
- 0296US9765142B2TEM8 antibodies and their use in treatment and detection of tumorsUS HEALTH·Filed 2014·Granted Sep 19, 2017·31 cites·49 claims
- 0394US9861621B2LPT-723 and immune checkpoint inhibitor combinations and methods of treatmentBIOMED VALLEY DISCOVERIES INC·Filed 2016·Granted Jan 9, 2018·16 cites·67 claims
- 0493US11471494B2Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2018·Granted Oct 18, 2022·7 cites·10 claims
- 0591US11723932B2Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2017·Granted Aug 15, 2023·5 cites·7 claims
- 0688US10604582B2Anti-CD276 antibodies (B7H3)THE US SECRETARY DEPARTMENT OF HEALTH·Filed 2015·Granted Mar 31, 2020·4 cites·37 claims
- 0787US11246859B2Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancersBIOMED VALLEY DISCOVERIES INC·Filed 2017·Granted Feb 15, 2022·2 cites·3 claims
- 0887US10881646B2Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancersBIOMED VALLEY DISCOVERIES INC·Filed 2017·Granted Jan 5, 2021·2 cites·12 claims
- 0986US10758614B2Combination therapies targeting tumor-associated stroma or tumor cells and topoisomeraseBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Sep 1, 2020·3 cites·10 claims
- 1085US2024374604A1Cancer treatments using combinations of cdk and erk inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2024·Application pending·0 cites
- 1184US12076324B2Cancer treatments using combinations of CDK and ERK inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2023·Granted Sep 3, 2024·0 cites·24 claims
- 1284US10485796B2LPT-723 and immune checkpoint inhibitor combinations and methods of treatmentBIOMED VALLEY DISCOVERIES INC·Filed 2017·Granted Nov 26, 2019·3 cites·14 claims
- 1383US11007184B2Cancer treatments using combinations of type 2 MEK and ERK inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2014·Granted May 18, 2021·3 cites·33 claims
- 1483US10668055B2Cancer treatment using combinations of ERK and RAF inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2014·Granted Jun 2, 2020·3 cites·27 claims
- 1579US2023110875A1Anti-cd276 polypeptides, proteins, and chimeric antigen receptorsTHE UNITED STATES OF AMERICA AS PRESENTED BY THE SEC DEP OF HEALTH·Filed 2022·Application pending·0 cites
- 1678US10716782B2LPT-723 and immune checkpoint inhibitor combinations and methods of treatmentBIOMED VALLEY DISCOVERIES INC·Filed 2019·Granted Jul 21, 2020·1 cites·20 claims
- 1777US11007183B2Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2014·Granted May 18, 2021·1 cites·22 claims
- 1877US10617723B2C. novyi for the treatment of solid tumors in humansBIOMED VALLEY DISCOVERIES INC·Filed 2014·Granted Apr 14, 2020·1 cites·45 claims
- 1977US10604583B2Anti-CD276 polypeptides, proteins, and chimeric antigen receptorsTHE UNITED STATES OF AMERICA AS PRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2017·Granted Mar 31, 2020·1 cites·22 claims
- 2076US11679112B2Cancer treatments using combinations of CDK and ERK inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2021·Granted Jun 20, 2023·0 cites·50 claims
- 2176US7745165B2Phosphatase associated with metastasisUNIV JOHNS HOPKINS·Filed 2004·Granted Jun 29, 2010·4 cites·19 claims
- 2274US2022378852A1C. novyi for the treatment of solid tumors in humansBIOMED VALLEY DISCOVERIES INC·Filed 2022·Application pending·0 cites
- 2373US11013743B2Cancer treatments using combinations of CDK and ERK inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2014·Granted May 25, 2021·0 cites·33 claims
- 2473US9757424B2Compositions and methods of treating gliomasBIOMED VALLEY DISCOVERIES INC·Filed 2012·Granted Sep 12, 2017·1 cites·8 claims
- 2573US9181340B2TEM8 antibodies, conjugates thereof, and their useST CROIX BRAD·Filed 2012·Granted Nov 10, 2015·5 cites·37 claims
- 2673US2025381235A1Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-ctla-4 and/or anti-pd-1 antibodies to treat solid tumor malignanciesUNIV JOHNS HOPKINS·Filed 2025·Application pending·0 cites
- 2771US11135225B2Cancer treatments using combinations of CDK and ERK inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2020·Granted Oct 5, 2021·0 cites·22 claims
- 2871US11033537B2LPT-723 and immune checkpoint inhibitor combinations and methods of treatmentBIOMED VALLEY DISCOVERIES INC·Filed 2020·Granted Jun 15, 2021·0 cites·35 claims
- 2971US2021038587A1Methods and compositions for treating non-erk mapk pathway inhibitor-resistant cancersBIOMED VALLEY DISCOVERIES INC·Filed 2020·Application pending·0 cites
- 3070US11439669B2C. novyi for the treatment of solid tumors in humansBIOMED VALLEY DISCOVERIES INC·Filed 2020·Granted Sep 13, 2022·0 cites·45 claims
- 3169US11512138B2Anti-CD276 polypeptides, proteins, and chimeric antigen receptorsTHE UNITED STATES OF AMERICA AS PRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2020·Granted Nov 29, 2022·0 cites·20 claims
- 3269US2023226122A1Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 3368US12433920B2C. novyi for the treatment of solid tumors in non-human animalsBIOMED VALLEY DISCOVERIES INC·Filed 2014·Granted Oct 7, 2025·0 cites·39 claims
- 3467US11851498B2Anti-CD276 antibodies (B7H3)THE US SECRETARY DEPARTMENT OF HEALTH·Filed 2020·Granted Dec 26, 2023·0 cites·20 claims
- 3564US2024180974A1Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 3660US10196443B2TEM8 antibodies and their use in treatment and detection of tumorsUS HEALTH·Filed 2017·Granted Feb 5, 2019·0 cites·33 claims
- 3754US12427173B2Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignanciesUNIV JOHNS HOPKINS·Filed 2015·Granted Sep 30, 2025·0 cites·10 claims
- 3853US2016317519A1Methods and compositions for treating non-erk mapk pathway inhibitor-resistant cancersBIOMED VALLEY DISCOVERIES INC·Filed 2016·Application pending·0 cites
- 3947US2014228248A1Methods and compositions for detecting infectionsBIOMED VALLEY DISCOVERIES INC·Filed 2012·Application pending·0 cites
- 4047US2016145355A1Bispecific antibodiesBIOMED VALLEY DISCOVERIES INC·Filed 2014·Application pending·0 cites
- 4145US10799584B2Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agentsBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Oct 13, 2020·0 cites·6 claims
- 4245US2016310477A1Cancer treatments using combinations of mek type 1 and erk inhibitorsBIOMED VALLEY DISCOVERIES INC·Filed 2014·Application pending·0 cites
- 4344US11033620B2Combination therapies targeting tumor-associated stroma or tumor cells and microtubulesBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Jun 15, 2021·0 cites·13 claims
- 4444US10758613B2Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cellsBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Sep 1, 2020·0 cites·11 claims
- 4543US11034757B2Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculatureBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Jun 15, 2021·0 cites·6 claims
- 4642US10758526B2Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathwaysBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Sep 1, 2020·0 cites·11 claims
- 4740US11033621B2Combination therapies targeting tumor-associated stroma or tumor cellsBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Jun 15, 2021·0 cites·12 claims
- 4839US10434174B2Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cellsBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Oct 8, 2019·0 cites·37 claims
- 4938US2017114133A1Tem8 antibodies and methods of useBIOMED VALLEY DISCOVERIES INC·Filed 2015·Application pending·0 cites
- 5035US2015018360A1Compositions and methods for treating metabolic disordersHALSE REZA·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Saurabh Saha files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →